South and Central America Soft Tissue Repair Market Analysis, Size, and Share by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

South and Central America Soft Tissue Repair Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Fixation Instruments and Tissue Mesh/Patch) and Application (Orthopedic Repair, Hernia Repair, Breast Reconstruction, Pelvic and Vaginal Prolapse Repair, Skin Repair, Dental Repair, Dural Repair, and Others)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025760
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 140
Page Updated: Nov 2021

The South and Central America soft tissue repair market is expected to grow from US$ 592.62 million in 2021 to US$ 821.53 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028.



Playing sports benefits adolescents physiologically, psychologically, and socially. It helps improve health conditions, self-esteem, and social interactions, alongside decreasing the risk of depression. However, sports practice is inevitably linked with the occurrence of injuries. Also, ~3.5 million injuries are reported in the country each year, and ~75,000 children of age 14 and below are treated for these injuries. This high participation rate of children in sports, coupled with an increase in injuries, is creating demand for sports medicines. Contact sports such as basketball and football, involving contact and collision, possess a higher rate of sports injuries. This leads to severe injuries to joints, bones, and tendons, and other soft tissues. Such injuries require emergency treatment or even surgical procedures. As per Spinal Cord, Inc., ~170,000 children with basketball-related injuries were treated in hospital emergency rooms. Thus, the rising prevalence of sports injuries is contributing to the soft tissue repair market growth.

The imposition of lockdown across South and Central America restricted the access to health system facilities, which negatively impacted the treatment and management of acute and chronic cardiovascular diseases. However, the COVID-19 outbreak is having a critical impact on medical care in the region. Additionally, the nations are known for medical tourism, which the pandemic has also hit. The second wave of COVID-19 outbreak affected Brazil, Chile, Peru, Argentina, Uruguay, and Colombia. During the COVID-19 pandemic, the healthcare system in the region experienced the shortage of hospital beds. The region already lags behind in the research and development activities. However, the limited soft tissue repair industry is negatively impacted by this crisis. Factors such as closing of many manufacturing sites followed by lack of investment due to economic slowdown hinders country’s healthcare infrastructure.

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South and Central America soft tissue repair market. Technological developments in regenerative medicine and new product launches by South and Central America and local players are likely to be instrumental in the future growth of the soft tissue repair market players. Cutting-edge technologies offer competitive advantages to companies. In July 2021, B.D. acquired Tepha, Inc., a leading developer and manufacturer of proprietary resorbable polymer technology. The poly 4-hydroxybutyric acid (P4HB) technology platform, Tepha's proprietary resorbable polymer, provides additional innovation potential that can accelerate the growth of B.D.'s surgical mesh portfolio focused on new areas of soft tissue repair, reconstruction, and regeneration. In April 2020, In2Bones launched ClearGuard LE Endoscopic Soft Tissue Release System to treat a variety of foot problems. The ClearGuard LE Endoscopic Soft Tissue Release System gives orthopedic and podiatric specialists an easy-to-use, repeatable, and cost-effective system for high-volume lower extremity soft tissue surgeries on plantar fascia, gastrocnemius, tarsal tunnel, and Morton’s neuroma. Further, Smith & Nephew, one of the key players in the soft tissue repair market, is working to develop advanced surgical techniques related to soft tissue injuries of the knee, including the most common injuries of torn menisci anterior cruciate ligament rupture.
South and Central America soft tissue repair market
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South and Central America Soft Tissue Repair Market Segmentation

  • South and Central America Soft Tissue Repair Market – By Product
    • Fixation Instruments
    • Tissue Mesh/Patch
  • South and Central America Soft Tissue Repair Market – By Application
    • Orthopedic Repair
    • Hernia Repair
    • Breast Reconstruction
    • Pelvic and Vaginal Prolapse Repair
    • Skin Repair
    • Dental Repair
    • Dural Repair
    • Others
  • South and Central America Soft Tissue Repair Market – By Country
    • Brazil
    • Argentina
    • Rest of South and Central America

South and Central America Soft Tissue Repair Report Scope

Report Attribute Details
Market size in 2021 US$ 592.62 Million
Market Size by 2028 US$ 821.53 Million
Global CAGR (2021 - 2028) 4.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Fixation Instruments and Tissue Mesh/Patch
By Application
  • Orthopedic Repair
  • Hernia Repair
  • Breast Reconstruction
  • Pelvic and Vaginal Prolapse Repair
  • Skin Repair
  • Dental Repair
  • Dural Repair
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Smith & Nephew
  • DePuy Synthes
  • Arthrex, Inc.
  • Medtronic
  • Integra Life Sciences Corporation
  • Stryker Corporation
  • BD
  • Allergan Plc.
  • W. L. Gore and Associates, Inc.
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo